| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 777 | 60.517 | 80.110 | 77.570 | 88.286 | 109.638 | 86.370 | 108.605 |
| Total Income - EUR | - | - | 777 | 60.520 | 80.127 | 77.576 | 88.396 | 109.659 | 86.390 | 113.891 |
| Total Expenses - EUR | - | - | 1.842 | 27.096 | 39.252 | 37.514 | 32.800 | 51.893 | 64.485 | 65.880 |
| Gross Profit/Loss - EUR | - | - | -1.065 | 33.424 | 40.876 | 40.062 | 55.596 | 57.766 | 21.905 | 48.011 |
| Net Profit/Loss - EUR | - | - | -1.088 | 32.715 | 40.110 | 39.317 | 54.712 | 56.772 | 21.169 | 44.594 |
| Employees | - | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Recipio Neuro Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 8.636 | 6.197 | 5.253 | 5.066 | 40.499 | 31.212 | 20.611 | 12.016 |
| Current Assets | - | - | 155 | 27.431 | 35.670 | 34.980 | 28.723 | 80.974 | 22.756 | 35.579 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 2.728 | 2.499 | 3.359 | 2.509 | 42.884 | 3.480 | 11.645 |
| Cash | - | - | 155 | 24.702 | 33.170 | 31.621 | 26.214 | 38.090 | 19.276 | 23.933 |
| Shareholders Funds | - | - | -1.044 | 31.690 | 39.113 | 38.339 | 53.756 | 56.821 | 21.218 | 44.642 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 9.836 | 1.939 | 1.809 | 1.707 | 15.466 | 55.366 | 22.150 | 2.953 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Recipio Neuro Srl